It's used to treat and prevent malaria infection, and to reduce symptoms and progression of autoimmune diseases such as lupus, rheumatoid arthritis, and others. Malaria is spread by mosquitoes, which transmit the parasites that cause the infection, usually in tropical and subtropical parts of the world. Plaquenil mediates cold symptoms Does chloroquine decrease potassium levels Hydroxychloroquine. This substance brand name Plaquenil is currently under observation as a potential treatment for those with primary progressive multiple sclerosis. Hydroxychloroquine HCQ is an antimalarial drug with immunomodulatory effects that is widely used in combination with other disease suppressing medications in the treatment of rheumatoid arthritis RA and systemic lupus erythematosus SLE. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. For example, it may be combined with an antibiotic to treat chronic Q-fever, which humans usually catch from farm animals or raw milk. Plaquenil is used to treat other types of infections too. Hydroxychloroquine multiple sclerosis I am taking plaquenil, 200 ms, once a day. I would like to., Hydroxychloroquine reduces microglial activity and. 200 mg plaquenilPlaquenil missed doseHydroxychloroquine blogPlaquenil 100mg tablet doses Multiple Sclerosis Society. Registered charity nos 1139257 / SC041990. Registered as a limited company in England and Wales 07451571 GABAPENTIN & HYDROXYCHLOROQUINE Multiple Sclerosis Society. Hydroxychloroquine Plaquenil. Will you have Multiple sclerosis with Hydroxychloroquine.. Jan 25, 2014 I don't believe that you risk dangers like you would with suddenly stopping a beta blocker or something along those lines. 200mg is a low dose and Plaquenil is generally regarded as a mild drug anyway compared to Methotrexate, etc. Regardless, it's always best to check with your doc. Hydroxychloroquine HCQ is a medication that has been shown to decrease the activity of human microglia in laboratory experiments. Animal experiments have also shown that treatment with HCQ can reduce the disease activity of an animal model of MS. Siponimod versus placebo in secondary progressive multiple sclerosis EXPAND a double-blind, randomised, phase 3 study. Lancet 391, 1263–1273 2018. This study reports that siponimod treatment led to a 21% reduced risk of disability progression in SPMS.